May 1, 2026

TRIPURA STAR NEWS

Tripura's Latest News, Views & News Portal

Union Minister J. P. Nadda Visits NIPER Mohali, Reviews Biopharma Research And Innovation.

Spread the love

New Delhi, Delhi, 1st of May 2026 : Union Minister for Chemicals & Fertilizers and Health & Family Welfare Shri. Jagat Prakash Nadda visited the National Institute of Pharmaceutical Education and Research (NIPER), Mohali today. During the visit, Minister inaugurated the NIPER Medicinal Succulents Garden.

Shri Nadda reviewed the institute’s strategic vision, research priorities, and innovation ecosystem. A comprehensive presentation by Prof. Dulal Panda Director, NIPER Mohali highlighted key performance indicators and the roadmap for strengthening research and industry linkages. The institute showcased its Centres of Excellence, including advanced work in biopharmaceuticals and emerging therapeutic domains, along with ongoing initiatives in technology transfer and commercialization.

Addressing the gathering, Shri Nadda emphasized the Government of India’s commitment to positioning the country at the forefront of biopharmaceutical advancements, particularly in APIs, key starting materials, synthesis intermediates, and biologics. He underscored the importance of strengthening research infrastructure and assured continued policy support and funding to accelerate innovation and execution in the sector. He also appreciated the institute’s role in nurturing skilled, industry-ready professionals contributing to national growth.

Shri Manoj Joshi, Secretary, Department of Pharmaceuticals interacted with faculty and students, inviting suggestions on enhancing industry collaboration, technology transfer, and translational research outcomes. He emphasized the need for reforms in the reward system to drive performance, suggesting incentives for faculty securing external funding and increasing industry-sponsored research. He also stressed the importance of transitioning from “paper patents” to real-world translation and commercialization to enhance national impact.

Highlighting the institute’s contributions, Prof. Dulal Panda reaffirmed its focus on research excellence and its growing network of distinguished alumni. He outlined the institute’s active role in advancing the Government’s Biopharma SHAKTI mission through cutting-edge work in cell and gene therapies, biosimilars, medical devices, AI-driven pharmacoinformatics, and advanced drug delivery systems. The introduction of new Master’s programmes in Biopharmaceuticals and Regulatory Affairs was also noted as a step towards building future-ready talent.

 The visit was followed by a Technology Showcase in the Convention Centre foyer, where the Union Minister reviewed posters and prototypes demonstrating translational research outcomes. The showcase featured industry collaborations, patents, and clinical trial initiatives undertaken by NIPER.
The visit underscores the Government of India’s sustained focus on strengthening pharmaceutical education, promoting innovation, and advancing research and development to build a robust and self-reliant biopharmaceutical ecosystem.

About The Author